Name | E3 ligase Ligand-Linker Conjugates 9 |
---|
Description | E3 ligase Ligand-Linker Conjugates 9 is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology. |
---|---|
Related Catalog | |
Target |
E3 Ligase Ligand-Linker Conjugate[1] |
In Vitro | E3 ligase Ligand-Linker Conjugates 9 uses the VHL ligand[1]. The linker is 6-2-2-2-2-2-2. The linkers contain a mixture of hydrophobic and hydrophilic moieties to balance the hydrophobicity/hydrophilicity of the resulting hybrid compounds. PROTACs that induce the degradation of an oncogenic tyrosine kinase, BCR-ABL has been developed. E3 ligase Ligand-Linker Conjugates 9 can be attached to potent TKIs (bosutinib and dasatinib) that mediate the degradation of c-ABL and BCR-ABL by hijacking either CRBN or VHL E3 ubiquitin ligase [2]. |
References |
[1]. US 20170121321 A1 |
Molecular Formula | C40H63ClN4O10S |
---|---|
Molecular Weight | 827.47 |
Storage condition | 2-8℃ |